Literature DB >> 28716900

Structural insights into the extracellular recognition of the human serotonin 2B receptor by an antibody.

Andrii Ishchenko1, Daniel Wacker2, Mili Kapoor3, Ai Zhang3, Gye Won Han1, Shibom Basu4, Nilkanth Patel5, Marc Messerschmidt6, Uwe Weierstall7, Wei Liu8, Vsevolod Katritch5, Bryan L Roth2,9,10, Raymond C Stevens1,5, Vadim Cherezov11.   

Abstract

Monoclonal antibodies provide an attractive alternative to small-molecule therapies for a wide range of diseases. Given the importance of G protein-coupled receptors (GPCRs) as pharmaceutical targets, there has been an immense interest in developing therapeutic monoclonal antibodies that act on GPCRs. Here we present the 3.0-Å resolution structure of a complex between the human 5-hydroxytryptamine 2B (5-HT2B) receptor and an antibody Fab fragment bound to the extracellular side of the receptor, determined by serial femtosecond crystallography with an X-ray free-electron laser. The antibody binds to a 3D epitope of the receptor that includes all three extracellular loops. The 5-HT2B receptor is captured in a well-defined active-like state, most likely stabilized by the crystal lattice. The structure of the complex sheds light on the mechanism of selectivity in extracellular recognition of GPCRs by monoclonal antibodies.

Entities:  

Keywords:  GPCR; X-ray free-electron laser; active state; antibody recognition; serial femtosecond crystallography

Mesh:

Substances:

Year:  2017        PMID: 28716900      PMCID: PMC5547598          DOI: 10.1073/pnas.1700891114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Ligand binding characteristics of CXCR4 incorporated into paramagnetic proteoliposomes.

Authors:  G J Babcock; T Mirzabekov; W Wojtowicz; J Sodroski
Journal:  J Biol Chem       Date:  2001-08-06       Impact factor: 5.157

Review 2.  Mechanism of action of therapeutic monoclonal antibodies: promises and pitfalls of in vitro and in vivo assays.

Authors:  Josée Golay; Martino Introna
Journal:  Arch Biochem Biophys       Date:  2012-02-25       Impact factor: 4.013

3.  Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.

Authors:  Kazuhito Yamamoto; Atae Utsunomiya; Kensei Tobinai; Kunihiro Tsukasaki; Naokuni Uike; Kimiharu Uozumi; Kazunari Yamaguchi; Yasuaki Yamada; Shuichi Hanada; Kazuo Tamura; Shigeo Nakamura; Hiroshi Inagaki; Koichi Ohshima; Hitoshi Kiyoi; Takashi Ishida; Kouji Matsushima; Shiro Akinaga; Michinori Ogura; Masao Tomonaga; Ryuzo Ueda
Journal:  J Clin Oncol       Date:  2010-02-22       Impact factor: 44.544

4.  Antigenically distinct conformations of CXCR4.

Authors:  F Baribaud; T G Edwards; M Sharron; A Brelot; N Heveker; K Price; F Mortari; M Alizon; M Tsang; R W Doms
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies.

Authors:  Cédric Blanpain; Jean-Marie Vanderwinden; Josef Cihak; Valérie Wittamer; Emmanuel Le Poul; Hassan Issafras; Manfred Stangassinger; Gilbert Vassart; Stefano Marullo; Detlef Schlndorff; Marc Parmentier; Matthias Mack
Journal:  Mol Biol Cell       Date:  2002-02       Impact factor: 4.138

6.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

7.  Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser.

Authors:  Yanyong Kang; X Edward Zhou; Xiang Gao; Yuanzheng He; Wei Liu; Andrii Ishchenko; Anton Barty; Thomas A White; Oleksandr Yefanov; Gye Won Han; Qingping Xu; Parker W de Waal; Jiyuan Ke; M H Eileen Tan; Chenghai Zhang; Arne Moeller; Graham M West; Bruce D Pascal; Ned Van Eps; Lydia N Caro; Sergey A Vishnivetskiy; Regina J Lee; Kelly M Suino-Powell; Xin Gu; Kuntal Pal; Jinming Ma; Xiaoyong Zhi; Sébastien Boutet; Garth J Williams; Marc Messerschmidt; Cornelius Gati; Nadia A Zatsepin; Dingjie Wang; Daniel James; Shibom Basu; Shatabdi Roy-Chowdhury; Chelsie E Conrad; Jesse Coe; Haiguang Liu; Stella Lisova; Christopher Kupitz; Ingo Grotjohann; Raimund Fromme; Yi Jiang; Minjia Tan; Huaiyu Yang; Jun Li; Meitian Wang; Zhong Zheng; Dianfan Li; Nicole Howe; Yingming Zhao; Jörg Standfuss; Kay Diederichs; Yuhui Dong; Clinton S Potter; Bridget Carragher; Martin Caffrey; Hualiang Jiang; Henry N Chapman; John C H Spence; Petra Fromme; Uwe Weierstall; Oliver P Ernst; Vsevolod Katritch; Vsevolod V Gurevich; Patrick R Griffin; Wayne L Hubbell; Raymond C Stevens; Vadim Cherezov; Karsten Melcher; H Eric Xu
Journal:  Nature       Date:  2015-07-22       Impact factor: 49.962

8.  Activation and allosteric modulation of a muscarinic acetylcholine receptor.

Authors:  Andrew C Kruse; Aaron M Ring; Aashish Manglik; Jianxin Hu; Kelly Hu; Katrin Eitel; Harald Hübner; Els Pardon; Celine Valant; Patrick M Sexton; Arthur Christopoulos; Christian C Felder; Peter Gmeiner; Jan Steyaert; William I Weis; K Christopher Garcia; Jürgen Wess; Brian K Kobilka
Journal:  Nature       Date:  2013-11-20       Impact factor: 49.962

Review 9.  Engineering therapeutic antibodies targeting G-protein-coupled receptors.

Authors:  Migyeong Jo; Sang Taek Jung
Journal:  Exp Mol Med       Date:  2016-02-05       Impact factor: 8.718

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  15 in total

1.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

Review 2.  Structural insights into emergent signaling modes of G protein-coupled receptors.

Authors:  Ieva Sutkeviciute; Jean-Pierre Vilardaga
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

3.  Signaling snapshots of a serotonin receptor activated by the prototypical psychedelic LSD.

Authors:  Can Cao; Ximena Barros-Álvarez; Shicheng Zhang; Kuglae Kim; Marc A Dämgen; Ouliana Panova; Carl-Mikael Suomivuori; Jonathan F Fay; Xiaofang Zhong; Brian E Krumm; Ryan H Gumpper; Alpay B Seven; Michael J Robertson; Nevan J Krogan; Ruth Hüttenhain; David E Nichols; Ron O Dror; Georgios Skiniotis; Bryan L Roth
Journal:  Neuron       Date:  2022-09-09       Impact factor: 18.688

Review 4.  "Selective" serotonin 5-HT2A receptor antagonists.

Authors:  Austen B Casey; Meng Cui; Raymond G Booth; Clinton E Canal
Journal:  Biochem Pharmacol       Date:  2022-04-04       Impact factor: 6.100

Review 5.  Structural biology of G protein-coupled receptors: new opportunities from XFELs and cryoEM.

Authors:  Andrii Ishchenko; Cornelius Gati; Vadim Cherezov
Journal:  Curr Opin Struct Biol       Date:  2018-03-16       Impact factor: 6.809

Review 6.  Serial Femtosecond Crystallography of G Protein-Coupled Receptors.

Authors:  Benjamin Stauch; Vadim Cherezov
Journal:  Annu Rev Biophys       Date:  2018-03-15       Impact factor: 12.981

7.  The discovery of a new antibody for BRIL-fused GPCR structure determination.

Authors:  Hikaru Miyagi; Hidetsugu Asada; Michihiko Suzuki; Yuichi Takahashi; Mai Yasunaga; Chiyo Suno; So Iwata; Jun-Ichi Saito
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

8.  Rapid identification of highly potent human anti-GPCR antagonist monoclonal antibodies.

Authors:  Martin J Scott; Amanda Jowett; Martin Orecchia; Peter Ertl; Larissa Ouro-Gnao; Julia Ticehurst; David Gower; John Yates; Katie Poulton; Carol Harris; Michael J Mullin; Kathrine J Smith; Alan P Lewis; Nick Barton; Michael L Washburn; Ruud de Wildt
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

9.  Structure-guided discovery of a single-domain antibody agonist against human apelin receptor.

Authors:  Yanbin Ma; Yao Ding; Xianqiang Song; Xiaochuan Ma; Xun Li; Ning Zhang; Yunpeng Song; Yaping Sun; Yuqing Shen; Wenge Zhong; Liaoyuan A Hu; Yingli Ma; Mei-Yun Zhang
Journal:  Sci Adv       Date:  2020-01-15       Impact factor: 14.136

10.  Common activation mechanism of class A GPCRs.

Authors:  Qingtong Zhou; Dehua Yang; Meng Wu; Yu Guo; Wanjing Guo; Li Zhong; Xiaoqing Cai; Antao Dai; Wonjo Jang; Eugene I Shakhnovich; Zhi-Jie Liu; Raymond C Stevens; Nevin A Lambert; M Madan Babu; Ming-Wei Wang; Suwen Zhao
Journal:  Elife       Date:  2019-12-19       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.